SB2474, the Youth Health Protection Act, would prohibit Illinois medical doctors from providing puberty blockers, cross-sex hormones, or specified gender-affirming surgeries to minors under 18 when the purpose is to treat gender dysphoria or gender discordance. It also bars medical doctors and mental health providers from referring minors for those chemical or surgical interventions. The bill defines key terms such as biological sex, gender dysphoria, detransition, and desistance, and includes extensive legislative findings asserting that such treatments are experimental, harmful, and unsupported by conclusive evidence.
The bill would also amend the Illinois Medical Practice Act of 1987 to make violation of the Youth Health Protection Act a disciplinary ground for physicians. In practice, that means a doctor who provides or refers for the prohibited care could face professional discipline by the licensing authority, including sanctions under existing medical licensing enforcement provisions. The bill is framed as a regulation of medical practice and would create a new statutory restriction on care for transgender and gender-diverse minors in Illinois.
Impact
SB2474 would add a new layer of state regulation over medical treatment for minors by prohibiting certain gender-related interventions and making noncompliance a licensure offense. It would affect physicians directly, and also mental health providers to the extent they make referrals for the prohibited care. By amending the Medical Practice Act, the bill would integrate enforcement into the existing physician discipline framework, allowing the Department of Financial and Professional Regulation and medical licensing bodies to sanction violations.
Sentiment
No committee transcripts or recorded votes were provided, so there is no documented legislative debate or vote history to gauge support or opposition. Based on the bill text itself, the sponsor’s position is strongly protective and restrictive toward gender-affirming care for minors, while the overall framing suggests the bill is intended to advance a conservative policy view on pediatric gender medicine. Because there is no recorded committee discussion in the provided materials, the public or legislative sentiment cannot be measured from proceedings, only inferred from the bill’s purpose and findings.
Contention
The central point of contention is whether minors should be allowed to receive puberty blockers, cross-sex hormones, or gender-related surgeries for gender dysphoria, and whether doctors should be permitted to refer patients for such care. Supporters of the bill would likely argue that these treatments are experimental, irreversible, and potentially harmful, while opponents would likely view the bill as interfering with medically accepted care and patient-provider decision-making. Another likely dispute is the bill’s broad disciplinary language, which could expose physicians and mental health providers to professional sanctions for providing or even referring for care that is legal in other contexts or states.